In Brief: Medicis
This article was originally published in The Rose Sheet
Executive Summary
Medicis: Mitchell Wortzman, PhD, to senior VP-research and development, reporting to Medicis Chairman and CEO Jonah Shacknai. Wortzman, who formerly served as Neutrogena Dermatologics division president, will head up research on "innovative" skin care treatments for physicians and patients, the company said. Medicis markets a range of dermatological cosmetics and skin care products through its Tx Systems division. The company recently signed an agreement with Abbott Labs, manufacturer of Ross Labs' Selsun Blue, to market a new skin care product. For the fiscal year ended June 30, the company reported sales growth of 62.6% to $41.2 mil. Earnings for the 12 months more than doubled to $17.3 mil...